These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38183395)

  • 1. Severity of COVID-19 Pneumonia in Kidney Transplant Recipients According to SARS-CoV-2 Vaccination.
    Choi S; Lee H; Eum SH; Min JW; Yoon HE; Yang CW; Chung BH
    Infect Chemother; 2023 Dec; 55(4):505-509. PubMed ID: 38183395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
    Kolb T; Fischer S; Müller L; Lübke N; Hillebrandt J; Andrée M; Schmitz M; Schmidt C; Küçükköylü S; Koster L; Kittel M; Weiland L; Dreyling KW; Hetzel G; Adams O; Schaal H; Ivens K; Rump LC; Timm J; Stegbauer J
    Kidney360; 2021 Sep; 2(9):1491-1498. PubMed ID: 35373105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India.
    Jasuja S; Jha V; Sagar G; Bahl A; Verma S; Jasuja N; Kaur J
    Clin Kidney J; 2022 Jul; 15(7):1312-1321. PubMed ID: 35747093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients.
    Körber N; Holzmann-Littig C; Wilkens G; Liao BH; Werz ML; Platen L; Cheng CC; Tellenbach M; Kappler V; Lehner V; Mijočević H; Christa C; Assfalg V; Heemann U; Schmaderer C; Protzer U; Braunisch MC; Bauer T; Renders L
    Front Immunol; 2023; 14():1172477. PubMed ID: 37063863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients.
    Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
    Front Immunol; 2022; 13():1050211. PubMed ID: 36532067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and Effects of Vaccination on Sars-Cov-2 Omicron Infection in Kidney Transplant Recipients.
    Chiu HF; Tsai SF; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2023 May; 55(4):820-823. PubMed ID: 37208223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
    Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
    Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in renal transplant recipients and general population: a comparative study of clinical, laboratory, and radiological features, severity, and outcome.
    Monfared A; Akhondzadeh L; Mousazadeh M; Jafari A; Khosravi M; Lebadi M; Aghajanzadeh P; Haghdar-Saheli Y; Movassaghi A; Ramezanzadeh E; Shobeirian F; Kazemnezhad E; Esmaeili S
    Virol J; 2021 Dec; 18(1):243. PubMed ID: 34876176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.
    Ohki Y; Kawabe M; Yamamoto I; Katsumata H; Nakada Y; Kobayashi A; Urabe F; Miki J; Yamada H; Kimura T; Matsuo N; Tanno Y; Horino T; Ohkido I; Yamamoto H; Yokoo T
    Front Microbiol; 2022; 13():922042. PubMed ID: 35756063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Vaccine-Induced T-Cell Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Kidney Transplant Recipients.
    Tometten I; Landmann S; Kantauskaite M; Lamberti J; Hillebrandt J; Müller L; Kittel M; Kolb T; Ivens K; Schmitz M; Voges A; Adams O; Andrée M; Schaal H; Lübke N; Königshausen E; Rump LC; Stegbauer J; Timm J
    J Infect Dis; 2023 Mar; 227(5):641-650. PubMed ID: 36408631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region.
    Maritati F; Cerutti E; Zuccatosta L; Fiorentini A; Finale C; Ficosecco M; Cristiano F; Capestro A; Balestra E; Taruscia D; Vivarelli M; Donati A; Perna GP; Giacometti A; Tavio M; Onesta M; Di Sante L; Ranghino A
    Transpl Infect Dis; 2020 Oct; 22(5):e13377. PubMed ID: 32573895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose.
    Kühn T; Speer C; Morath C; Bartenschlager M; Kim H; Beimler J; Buylaert M; Nusshag C; Kälble F; Reineke M; Töllner M; Klein K; Blank A; Parthé S; Schnitzler P; Zeier M; Süsal C; Bartenschlager R; Tran TH; Schaier M; Benning L
    Transplantation; 2023 May; 107(5):1139-1150. PubMed ID: 36617671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study.
    Hovd M; Åsberg A; Munthe LA; Heldal K; Reisæter AV; Vaage JT; Lund-Johansen F; Midtvedt K
    EClinicalMedicine; 2023 Jun; 60():102035. PubMed ID: 37362086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose.
    Werbel WA; Karaba AH; Chiang TP; Massie AB; Brown DM; Watson N; Chahoud M; Thompson EA; Johnson AC; Avery RK; Cochran WV; Warren D; Liang T; Fribourg M; Huerta C; Samaha H; Klein SL; Bettinotti MP; Clarke WA; Sitaras I; Rouphael N; Cox AL; Bailey JR; Pekosz A; Tobian AAR; Durand CM; Bridges ND; Larsen CP; Heeger PS; Segev DL;
    Am J Transplant; 2023 Jun; 23(6):744-758. PubMed ID: 36966905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
    Kho MML; Messchendorp AL; Frölke SC; Imhof C; Koomen VJ; Malahe SRK; Vart P; Geers D; de Vries RD; GeurtsvanKessel CH; Baan CC; van der Molen RG; Diavatopoulos DA; Remmerswaal EBM; van Baarle D; van Binnendijk R; den Hartog G; de Vries APJ; Gansevoort RT; Bemelman FJ; Reinders MEJ; Sanders JF; Hilbrands LB;
    Lancet Infect Dis; 2023 Mar; 23(3):307-319. PubMed ID: 36354032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination.
    Zhang L; Yang J; Deng M; Xu C; Lai C; Deng X; Wang Y; Zhou Q; Liu Y; Wan L; Li P; Fang J; Hou J; Lai X; Ma F; Li N; Li G; Kong W; Zhang W; Li J; Cao M; Feng L; Chen Z; Chen L; Ji T
    Sci Rep; 2023 May; 13(1):7263. PubMed ID: 37142713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of kidney transplant recipients admitted to a tertiary care transplant center with SARS-CoV-2.
    Zona EE; Gibes ML; Jain AS; Smith JA; Garonzik-Wang JM; Mandelbrot DA; Parajuli S
    World J Virol; 2024 Jun; 13(2):95273. PubMed ID: 38984080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short and mid-term SARS-CoV-2 antibody response after inactivated COVID-19 vaccine in hemodialysis and kidney transplant patients.
    Dheir H; Tocoglu A; Toptan H; Pinar M; Demirci T; Koroglu M; Yaylaci S; Genc AB; Genc AC; Firat N; Karabay O; Sipahi S
    J Med Virol; 2022 Jul; 94(7):3176-3183. PubMed ID: 35277975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolic Acid Exposure Determines Antibody Formation Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study.
    Meziyerh S; Bouwmans P; van Gelder T; van der Helm D; Messchendorp L; van der Boog PJM; de Fijter JW; Moes DJAR; de Vries APJ;
    Clin Pharmacol Ther; 2023 Jul; 114(1):118-126. PubMed ID: 36789469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.